Cannabis Campaigners' Guide News Database result:
Inhaled cannabis improved neuropathic pain in clinical study
IACM-Bulletin of 30 December 2012
Sunday 30 Dec 2012
There were no significant differences between the two groups receiving low and medium doses of cannabis. An average of about three patients had to be treated for one patient to benefit with a pain reduction of more than 30%. Authors noted that these results "are compatible to those of traditional neuropathic pain medications" and that psychoactive effects were minimal and well tolerated. They concluded that "vaporised cannabis, even at low doses, may present an effective option for patients with treatment-resistant neuropathic pain."
Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain. J Pain. 2012 Dec 10. [in press]
After you have finished reading this article you can click here to go back.
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!